pharma · Melanoma · Alcohol Use Disorder · ADIL
ADIAL PHARMACEUTICALS
ADIAL PHARMACEUTICALS, INC.
ADIAL PHARMACEUTICALS clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- CHARLOTTESVILLE, VA, ES
- Founded
- 2021
- Employees
- 16
- Programs
- 6
- Drugs
- 9
- Patents
- 1
ADIAL PHARMACEUTICALS projects
6 ClinicalTrials.gov programs sponsored by ADIAL PHARMACEUTICALS.
ADIAL PHARMACEUTICALS has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AD04 (ondansetron)
ADIAL PHARMACEUTICALS, INC.
Alcohol Use Disorder
1 trial -
Axitinib
ADIAL PHARMACEUTICALS, INC.
Melanoma
1 trial -
Trametinib (GSK1120212)
ADIAL PHARMACEUTICALS, INC.
Melanoma
1 trial -
Erythromycin lactobionate
ADIAL PHARMACEUTICALS, INC.
Diabetes Mellitus, Type 1
1 trial -
Nizatidine
ADIAL PHARMACEUTICALS, INC.
Gastroparesis
1 trial -
rhBMP-2 placement
ADIAL PHARMACEUTICALS, INC.
Tooth Loss
1 trial
Frequently asked questions
How many clinical projects does ADIAL PHARMACEUTICALS have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.